BioAxone BioSciences
BioAxone is committed to applying a deep understanding of axon regeneration and neuronal signaling pathways to transform the lives of patients afflicted with neurotrauma or neurovascular disorders. Led by a passionate management team augmented by 20 years of pioneering research, the company has identified and is developing a pipeline of drugs focused on nerve repair and regeneration.
02/28/2018
An estimated 12,500 spinal cord injuries occur every year. We are committed to finding a cure and our first-in-class product that promotes axon regeneration is in late-stage clinical trial. Our product is topically applied to the spinal cord in acute trauma surgery and is designed to help repair damaged circuits in the spinal cord. http://ow.ly/TpF330id4dk
02/26/2018
The anxiety of harboring a silent neurovascular disorder can be terrible - and lead to a hard choice - See stories on Boston-based WCVB Chronicle . http://ow.ly/ZxkB30id2tB. BioAxone is developing a drug to provide a non-surgical alternative for those with neurovascular disease.
The Choice of Her Life: The AVM Diagnosis Vanessa Garza felt like she had it all, but something was unsettling her: strange sounds she heard from time to time. When she went for a diagnosis, the results shocker her. She suffered from a rare brain condition that could be fatal.
Great blog by Dr. Ed Smith Boston Children's describing "What parents need to know" about cavernous angioma http://ow.ly/aiyX30id4XD
Great review by BioAxone Research Scientist, Dr. Woller published a review on "Pathways encoding nociception"
Click here to claim your Sponsored Listing.
Category
Website
Address
763 Concord Avenue
Cambridge, MA
02138